Lantern Pharma Inc.

LTRN | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.43

-$0.07 (-4.67%)

Sep 22, 2026, 2:12 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-17.12M	-20.78M	-15.96M	-14.26M	-12.36M	-5.91M
Depreciation & Amortization	17.28K	17.28K	14.62K	10.08K	6.76K	3.39K
Stock-Based Compensation	650.88K	732.89K	1.07M	1.19M	961.55K	1.19M
Other Working Capital	635.28K	2.23M	538.02K	-611.86K	599.96K	-939.06K
Other Non-Cash Items	139.02K	-10.32K	-5.17K	906.49K	203.22K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	635.28K	2.23M	538.02K	-611.86K	599.96K	-939.06K
Operating Cash Flow	-15.68M	-17.81M	-14.35M	-12.77M	-10.59M	-5.65M
Capital Expenditures	-1.72K	-12.6K	-18.73K	-27.84K	-15.5K	-16.14K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-14.72M	-17.28M	-8.2M	-3.91M	-19.58M	n/a
Sales Maturities Of Investments	25.78M	20.66M	7.28M	4.12M	64.09K	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	11.06M	3.37M	-930.21K	179.27K	-19.53M	-16.14K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	108.5K
Common Stock Repurchased	n/a	n/a	-500K	-2.48M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-139.75K	n/a	n/a	2.78M	-4.64M	-28.94M
Financial Cash Flow	1.5M	66.71K	-500K	-2.18M	63.42M	23.66M
Net Cash Flow	-3.09M	-14.43M	-15.81M	-14.78M	33.3M	18M
Free Cash Flow	-15.68M	-17.83M	-14.37M	-12.8M	-10.61M	-5.67M
Adj. Free Cash Flow	-16.33M	-18.56M	-15.43M	-13.98M	-11.57M	-6.86M
Maintenance CapEx	-1.72K	-12.6K	-14.62K	-10.08K	-6.76K	-3.39K
Growth CapEx	n/a	n/a	-4.12K	-17.76K	-8.74K	-12.75K
Owner Earnings	-15.68M	-17.83M	-14.36M	-12.78M	-10.6M	-5.66M